MedTrace Logo

Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy

NCT04278079 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2020-02-20

No results posted yet for this study

Summary

Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy

Conditions

  • Myopic Traction Maculopathy
  • Pars Plana Vitrectomy
  • Internal Limiting Membrane Peeling

Interventions

PROCEDURE

Pars Plana Vitrectomy with Internal Limiting Membrane peel

Pars plana vitrectomy with staining and peeling of internal limiting membrane

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-12-31
Completion
2020-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04278079 on ClinicalTrials.gov